acetylgalactosamine has been researched along with Cytomegalic Inclusion Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, T; Ohnishi, A; Shimoya, K; Yuki, N | 1 |
| Tagawa, Y; Takeuchi, H; Tsukaguchi, M; Yuki, N | 1 |
2 other study(ies) available for acetylgalactosamine and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
[Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
Topics: Acetylgalactosamine; Adult; Antibodies, Viral; Autoantibodies; Biomarkers; Cytomegalovirus; Cytomegalovirus Infections; Facial Paralysis; Female; G(M1) Ganglioside; G(M2) Ganglioside; Hepatitis, Viral, Human; Humans; Immunoglobulin G; Immunoglobulin M; Polyradiculoneuropathy | 1997 |
IgM anti-GM2 antibody in a patient with Guillain-Barré syndrome subsequent to cytomegalovirus hepatitis cross reacts with N-acetylgalactosaminyl GD1a.
Topics: Acetylgalactosamine; Adult; Autoantibodies; Cross Reactions; Cytomegalovirus Infections; G(M2) Ganglioside; Hepatitis, Viral, Human; Humans; Immunoglobulin M; Male; Polyradiculoneuropathy; Receptors, Immunologic | 1998 |